These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8785072)

  • 41. General population screening for cystic fibrosis is premature.
    Biesecker L; Bowles-Biesecker B; Collins F; Kaback M; Wilfond B
    Am J Hum Genet; 1992 Feb; 50(2):438-9. PubMed ID: 1734723
    [No Abstract]   [Full Text] [Related]  

  • 42. Disclosing to parents newborn carrier status identified by routine blood spot screening.
    Oliver S; Dezateux C; Kavanagh J; Lempert T; Stewart R
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003859. PubMed ID: 15495068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 workshop.
    MMWR Recomm Rep; 1997 Dec; 46(RR-16):1-24. PubMed ID: 9408048
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic screening and public health.
    Holtzman NA
    Am J Public Health; 1997 Aug; 87(8):1275-7. PubMed ID: 9279259
    [No Abstract]   [Full Text] [Related]  

  • 45. Is population screening for cystic fibrosis appropriate now?
    Gilbert F
    Am J Hum Genet; 1990 Feb; 46(2):394-5. PubMed ID: 1967902
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethical dimensions in genetic screening: a look into the future.
    Penticuff JH
    J Obstet Gynecol Neonatal Nurs; 1996; 25(9):785-9. PubMed ID: 8951116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCR-based cystic fibrosis (CF) carrier screening in a first-year medical student biochemistry laboratory.
    Grody WW; Kronquist KE; Lee EU; Edmond J; Rome LH
    Am J Hum Genet; 1993 Dec; 53(6):1352-5. PubMed ID: 8250051
    [No Abstract]   [Full Text] [Related]  

  • 49. Pros and cons of neonatal screening for cystic fibrosis.
    te Meerman GJ; Dankert-Roelse JE
    Adv Exp Med Biol; 1991; 290():83-92; discussion 92-5. PubMed ID: 1950760
    [No Abstract]   [Full Text] [Related]  

  • 50. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.
    Hussein N; Weng SF; Kai J; Kleijnen J; Qureshi N
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010849. PubMed ID: 26264938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for cystic fibrosis in primary care.
    Burn J
    BMJ; 1993 Jun; 306(6892):1558-9. PubMed ID: 8329910
    [No Abstract]   [Full Text] [Related]  

  • 52. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cystic fibrosis carrier screening practices in an ethnically diverse region: experience of the Genetic Network of the Empire State, Puerto Rico, and the U.S. Virgin Islands.
    Schwind EL; Wolfe M; Greendale K; Misra LM; Pass KA; Wallerstein R
    Genet Test; 1999; 3(2):215-8. PubMed ID: 10464670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for carriers of cystic fibrosis.
    Raeburn S
    BMJ; 1994 Jun; 308(6942):1451-2. PubMed ID: 8019273
    [No Abstract]   [Full Text] [Related]  

  • 55. AIDS and the future of reproductive freedom.
    Bayer R
    Milbank Q; 1990; 68(Suppl. 2):179-204. PubMed ID: 11653914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion of information about genetic risk within families.
    Ayme S; Macquart-Moulin G; Julian-Reynier C; Chabal F; Giraud F
    Neuromuscul Disord; 1993; 3(5-6):571-4. PubMed ID: 11660032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for cystic fibrosis and its evaluation.
    Wildhagen MF; ten Kate LP; Habbema JD
    Br Med Bull; 1998; 54(4):857-75. PubMed ID: 10367419
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reporting the results of cystic fibrosis carrier screening.
    Asch DA; Patton JP; Hershey JC; Mennuti MT
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):1-6. PubMed ID: 8420307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethical issues involved in establishing a registry for familial Alzheimer's disease.
    Godard B; Knoppers BM; Glass K; Grenon M; Bouchard R; Bouvier M; Goulet J; Gauvreau D
    Alzheimer Dis Assoc Disord; 1994; 8(2):79-93. PubMed ID: 8060610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perspectives in genetic screening. Principles and implications.
    Kaback MM
    Int J Technol Assess Health Care; 1994; 10(4):592-603. PubMed ID: 7843881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.